Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity
- PMID: 28333984
- PMCID: PMC5363846
- DOI: 10.1371/journal.pone.0174006
Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity
Abstract
A series of N,4-diaryl-1,3-thiazole-2-amines containing three aromatic rings with an amino linker were designed and synthesized as tubulin inhibitors and evaluated for their antiproliferative activity in three human cancer cell lines. Most of the target compounds displayed moderate antiproliferative activity, and N-(2,4-dimethoxyphenyl)-4-(4-methoxyphenyl)-1,3-thiazol-2-amine (10s) was determined to be the most potent compound. Tubulin polymerization and immunostaining experiments revealed that 10s potently inhibited tubulin polymerization and disrupted tubulin microtubule dynamics in a manner similar to CA-4. Moreover, 10s effectively induced SGC-7901 cell cycle arrest at the G2/M phase in both concentration- and time-dependent manners. The molecular docking results revealed that 10s could bind to the colchicine binding site of tubulin.
Conflict of interest statement
Figures








Similar articles
-
Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.Sci Rep. 2017 Sep 20;7(1):11997. doi: 10.1038/s41598-017-10860-7. Sci Rep. 2017. PMID: 28931885 Free PMC article.
-
Design, synthesis and bioevaluation of 2,7-diaryl-pyrazolo[1,5-a]pyrimidines as tubulin polymerization inhibitors.Bioorg Chem. 2021 Oct;115:105220. doi: 10.1016/j.bioorg.2021.105220. Epub 2021 Jul 29. Bioorg Chem. 2021. PMID: 34352709
-
Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents.Eur J Med Chem. 2019 Jun 1;171:1-10. doi: 10.1016/j.ejmech.2019.02.049. Epub 2019 Feb 18. Eur J Med Chem. 2019. PMID: 30901597
-
The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds.Curr Med Chem. 2001 Feb;8(2):203-10. doi: 10.2174/0929867013373714. Curr Med Chem. 2001. PMID: 11172675 Review.
-
The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.Curr Med Chem. 2004 Apr;11(8):1009-21. doi: 10.2174/0929867043455530. Curr Med Chem. 2004. PMID: 15078163 Review.
Cited by
-
Design, synthesis, and in vitro biological evaluation of novel benzimidazole tethered allylidenehydrazinylmethylthiazole derivatives as potent inhibitors of Mycobacterium tuberculosis.Medchemcomm. 2018 Oct 25;10(1):49-60. doi: 10.1039/c8md00389k. eCollection 2019 Jan 1. Medchemcomm. 2018. PMID: 30774854 Free PMC article.
-
Development and therapeutic potential of 2-aminothiazole derivatives in anticancer drug discovery.Med Chem Res. 2021;30(4):771-806. doi: 10.1007/s00044-020-02686-2. Epub 2021 Jan 15. Med Chem Res. 2021. PMID: 33469255 Free PMC article. Review.
-
Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors.Front Chem. 2025 Apr 16;13:1565699. doi: 10.3389/fchem.2025.1565699. eCollection 2025. Front Chem. 2025. PMID: 40308265 Free PMC article.
-
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities.Pharmaceuticals (Basel). 2024 Aug 31;17(9):1154. doi: 10.3390/ph17091154. Pharmaceuticals (Basel). 2024. PMID: 39338317 Free PMC article.
-
Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.Molecules. 2022 Jul 31;27(15):4898. doi: 10.3390/molecules27154898. Molecules. 2022. PMID: 35956848 Free PMC article.
References
-
- Stephens RE, Edds KT. Microtubules: structure, chemistry, and function. Physiol Rev. 1976; 56(4): 709–777. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources